First Light Asset Management
First Light Asset Management reported 31 stocks worth $1.6B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are NEO (10.9%), SIBN (8.1%) and AXGN (7.7%). Compared with Q1 2026, the fund opened new positions in TRVI and TCMD, added to NEO, SIBN and ELVN, trimmed AXGN, PVLA and TWST and sold out of WVE, VERA and MDXG.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() NEO Neogenomics Inc | $179M | 10.9% | 12.3M | +2.5M (+26%) | 8 of 8 | |
| 2 | ![]() SIBN Si-Bone Inc | $133M | 8.1% | 8.1M | +2.8M (+52%) | 8 of 8 | |
| 3 | ![]() AXGN Axogen Inc | $127M | 7.7% | 2.7M | −1.3M (−31%) | 8 of 8 | |
| 4 | APOGEE THERAPEUTICS INC | $123M | 7.5% | 930K | +354K (+61%) | 3 of 8 | |
| 5 | ![]() PVLA Palvella Therapeutics Inc NE | $118M | 7.2% | 772K | −209K (−21%) | 4 of 8 | |
| 6 | ![]() TWST Twist Bioscience Corp | $74.9M | 4.5% | 728K | −151K (−17%) | 7 of 8 | |
| 7 | ![]() ELVN Enliven Therapeutics Inc | $69.1M | 4.2% | 1.4M | +1.2M (+574%) | 2 of 8 | |
| 8 | ![]() GH Guardant Health Inc | $66.3M | 4.0% | 442K | +161K (+58%) | 8 of 8 | |
| 9 | ![]() MASS 908 Devices Inc | $54.7M | 3.3% | 6.3M | +210K (+3%) | 6 of 8 | |
| 10 | ![]() AMLX Amylyx Pharmaceuticals Inc | $54.3M | 3.3% | 3M | −167K (−5%) | 4 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
CENTESSA PHARMACEUTICALS PLC | $62M | 1.6M |
![]() WVE Wave Life Sciences Ltd | $13.4M | 1.8M |
![]() VERA Vera Therapeutics Inc | $12.6M | 314K |
![]() MDXG Mimedx Group Inc | $11.2M | 2.8M |
![]() SGP Spyglass Pharma Inc | $9.7M | 375K |
🔒 Free account: see all 6.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →First Light Asset Management 13F FAQ
What does First Light Asset Management own?
First Light Asset Management reported 31 stocks worth $1.6B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are NEO (10.9%), SIBN (8.1%) and AXGN (7.7%). The table above lists every position in the filing (the top 10 without an account).
What did First Light Asset Management buy and sell in Q2 2026?
Compared with Q1 2026: 2 new positions, 17 added to, 12 trimmed and 6 sold out. New positions include TRVI and TCMD. It sold all of WVE, VERA and MDXG.
When will First Light Asset Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is First Light Asset Management's portfolio worth?
The Q2 2026 filing reports $1.6B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.












